The Liver Meeting 2023-Leon Schiff State of the Art: Personalized Approach to HCC

Leon Schiff State of the Art: Personalized Approach to HCC

Video Transcription

Video Summary

The 2023 Leon Schiff state-of-the-art lecture honors Dr. Schiff, a hepatology pioneer. Dr. Schiff's legacy lives on through his son, Eugene Schiff, and the Schiff Center of Liver Diseases. Dr. Lewis Roberts discussed a personalized approach to hepatocellular carcinoma (HCC) treatment, emphasizing the need for individualized care based on biomarkers and tumor biology. He highlighted the global burden of liver cancer and the importance of early detection for better outcomes. Dr. Roberts presented a study on the impact of pretreatment biomarkers on patient outcomes, as well as research on maximizing the benefits of immune-based therapies through combinations like dendritic cell therapy and radiation. The goal is to improve response rates and outcomes for liver cancer patients through innovative treatment approaches.

Keywords

hepatology pioneer

individualized care

biomarkers

global burden

early detection

immune-based therapies

innovative treatment approaches